Treatment of Gastric Carcinoid Minoru Kawaguchi 1 , Yuu Takagi 2 , Hiromi Tokita 2 1The Fourth Department of Internal Medicine, Tokyo Medical University 2The Third Department of Surgery, Tokyo Medical University Keyword: 胃カルチノイド , 治療 , 内分泌細胞癌 , EMR , 悪性度 pp.1405-1415
Published Date 2000/10/25
DOI https://doi.org/10.11477/mf.1403104895
  • Abstract
  • Look Inside
  • Cited by

 This paper reports the current treatment of gastric carcinoid in our hospital and discusses it based on the literature. Our hospital has treated gastric carcinoid in 27 patients, 14 of whom underwent surgical resection and 13 of whom are still under observetion by EMR. Recurrence or death occurred in none of the patients, although lymph node metastasis occured in 1 patient with multiple carcinoids associated with hyergastrinemia who underwent surgery. In determining therapeutic policy for carcinoid tumors, their size, depth, and histological findings (degree of atypism and infiltration pattern) must be taken into account. If the carcinoid is 2 cm in diameter or smaller and its depth is SM or shallower, we first conduct EMR and then conduct additional gastrectomy with lymph node dissection or just monitor the patients condition depending on the pathological findings of the EMR material. If the carcinoid is greater than 2 cm in diameter or deeper than MP, surgical resection is conducted.

Copyright © 2000, Igaku-Shoin Ltd. All rights reserved.


電子版ISSN 1882-1219 印刷版ISSN 0536-2180 医学書院